Tag: nasdaq:fcsc

May 29, 2019

Fibrocell Receives FDA Regenerative Medicine Advanced Therapy Designation for FCX-007 Gene Therapy

Fibrocell Science (NASDAQ:FCSC) has announced that the US Food and Drug Administration (FDA) has granted the company Regenerative Medicine Advanced...
September 25, 2018

Investing in Stem Cell Treatments

Stem cell treatments have grabbed investor attention for years, but can be complex and potentially dangerous. Here is an overview...
September 25, 2018

Fibrocell Awarded $1.4 Million FDA Orphan Grant for FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa

Fibrocell Science (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today...
September 5, 2018

Fibrocell Announces FDA Fast Track Designation of FCX-013 for Treatment of Moderate to Severe Localized Scleroderma

Fibrocell Science (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today...